Topics and Expertise: CERSI

Dozens of presumed inactive ingredients may impact human biology

School scientists identify excipients with potential to cause side effects

FDA, academia, and industry join forces to shepherd new therapies to patients

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

USP/UCSF fellowship to support research in the quality and safety of medical products

A new fellowship, funded jointly by UCSF-Stanford CERSI and the U.S. Pharmacopeial Convention (USP), will support research into the inactive components of medications, which are known as excipients.

Giacomini named 2018 Volwiler Research Award recipient

Kathy Giacomini, PhD, has been named the 2018 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy.

Giacomini to receive North American Scientific Achievement Award

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

Update from the Dean - March 2017

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...

FDA funds UCSF-Stanford CERSI

The U.S. Food and Drug Administration has awarded the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) a five-year grant with up to $25 million in funding.

Giacomini honored with ASCPT Distinguished Service Award

Kathy Giacomini, PhD, has been named the 2017 recipient of the Henry W. Elliott Distinguished Service Award from the American Society for Clinical Pharmacology and Therapeutics (ASCPT).

The right dose: how pharmacy researchers are making medicine more precise

Reprinted courtesy of UCSF Magazine.

In the pediatric bone marrow transplant clinic, pharmacist Janel Boyle’s past and present collide.

She drifts past young patients—many of them infants and toddlers—and notes their beaming smiles and balding heads. Her gaze shifts to the parents, their...

FDA launches UCSF-Stanford center for innovation in drug development, regulation

The U.S. Food and Drug Administration (FDA) is tapping the UCSF School of Pharmacy and Stanford University to launch its first West Coast regulatory science center, focused on spurring innovation in the development and evaluation of safer and more effective medications.

Pages